Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial

• Valeria Saglimbene,

  Affiliations Sydney School of Public Health, Edward Ford Building, The University of Sydney, New South Wales, Australia, Diaverum Renal Services Group, Lund, Sweden

  ⨯
• Suetonia C. Palmer,

  Affiliation Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand

  http://orcid.org/0000-0001-7765-5871

  ⨯
• Jonathan C. Craig,

  Affiliation Sydney School of Public Health, Edward Ford Building, The University of Sydney, New South Wales, Australia

  ⨯
• Marinella Ruospo,

  Affiliations Diaverum Renal Services Group, Lund, Sweden, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy

  ⨯
• Antonio Nicolucci,

  Affiliation Center for Outcomes Research and clinical Epidemiology (CORESEARCH), Pescara, Italy

  ⨯
• Marcello Tonelli,

  Affiliation Cumming School of Medicine, Health Sciences Centre, University of Calgary, Foothills Campus, Calgary, Alberta, Canada

  ⨯
• David Johnson,

  Affiliations Department of Renal Medicine, Division of Medicine, University of Queensland at the Princess Alexandra Hospital, Woolloongabba, Queensland, Australia, Translational Research Institute, University of Queensland, Woolloongabba, Queensland, Australia

  ⨯
• Giuseppe Lucisano,

  Affiliation Center for Outcomes Research and clinical Epidemiology (CORESEARCH), Pescara, Italy

  ⨯
• Gabrielle Williams,

  Affiliation Sydney School of Public Health, Edward Ford Building, The University of Sydney, New South Wales, Australia

  ⨯
• Miriam Valentini,

  Affiliation Quintiles srl, Milan, Italy

  ⨯
• Daniela D’Alonzo,

  Affiliation ASL, Lanciano Vasto, Chieti, Italy

  ⨯
• Fabio Pellegrini,

  Affiliation Global Medical Biogen Idec, Cambridge, Massachusetts, United States of America

  ⨯
• Paolo Strippoli,

  Affiliation Department of Nephrology and Dialysis, Ospedale " A. Perrino", Brindisi, Italy

  ⨯
• Mario Salomone,

  Affiliation Department of Nephrology and Dialysis, Ospedale Maggiore di Chieri, Chieri, Italy

  ⨯
• Antonio Santoro,

  Affiliation Department of Nephrology and Dialysis, Policlinico S. Orsola-Malpighi, Bologna, Italy

  ⨯
• Stefano Maffei,

  Affiliation Department of Nephrology and Dialysis, Ospedale Maggiore di Chieri, Chieri, Italy

  ⨯
• Jörgen Hegbrant,

  Affiliation Diaverum Renal Services Group, Lund, Sweden

  ⨯
• Gianni Tognoni,

  Affiliation Mario Negri Institute for Pharmacological Research, Milano, Italy

  ⨯
• Giovanni F. M. Strippoli ,

  * E-mail: gfmstrippoli@gmail.com

  Affiliations Sydney School of Public Health, Edward Ford Building, The University of Sydney, New South Wales, Australia, Diaverum Renal Services Group, Lund, Sweden, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy

  http://orcid.org/0000-0002-6936-0616

  ⨯
•  [ ... ],
• for the CE-DOSE Study Investigators

  ¶Investigators in the Clinical Evaluation of the DOSe of Erythropoietins (C.E. DOSE) Study are provided in the Acknowledgments.

  ⨯
• [ view all ]
• [ view less ]